Compositions and Methods for an Oral Supplement to Oral Minoxidil for the Treatment of Alopecia
AssigneeFollea International
InventorOfer A. Goren
Life of this patent
Estimating the term…
Abstract
Embodiments can relate to compositions and methods for the treatment of hair loss, which can include treatment of alopecia. The compositions and methods relate to an oral supplement to oral minoxidil includes a SLC22A9 inducer, a HIF-alpha inducer, and/or an acidifying agent. Acidifying blood of a patient suffering from alopecia can cause mild acidosis which can up-regulate SLC22A9 and/or down-regulate AABC3. Inducing SLC22A9, inducing HIF-alpha, and/or acidifying blood of the patient can facilitate oral forms of minoxidil to enter hair follicles.
Claims21
An oral supplement to oral minoxidil, the oral supplement, comprising:
- a SLC22A9 inducer, a HIF-alpha inducer, and/or an acidifying agent.
A method for treating alopecia, the method comprising:
- treating for alopecia by:
- administering oral minoxidil to a patient suffering from alopecia;
- and
- administering an oral supplement before, during, and/or after administration of oral minoxidil, the oral supplement including a SLC22A9 inducer, a HIF-alpha inducer, and/or an agent to acidify blood of the patient.
- or
- treating for alopecia by administering an oral supplement containing oral minoxidil, the oral supplement further including a SLC22A9 inducer, a HIF-alpha inducer, and/or an agent to acidify blood of the patient.
An oral composition for treating alopecia, the composition, comprising:
- a SLC22A9 inducer, a HIF-alpha inducer, and/or an acidifying agent.
A method for treating alopecia, the method comprising:
- administering an oral composition to a patient suffering from alopecia, the oral composition comprising a SLC22A9 inducer, a HIF-alpha inducer, and/or an acidifying agent.
Dependencies are inferred from the claim text.